Fan 2016.
Methods | Parallel randomized controlled trial |
Participants | Patients diagnosed with rheumatic valve diseases undergoing heart valve replacement operations |
Interventions | Telmisartan, captopril, and placebo |
Outcomes | Pulmonary vascular resistance, A‐aDO2, pulmonary neutrophil count, SOD malondialdehyde, NO, angiotensin II; Complications and hospital time. |
Notes |